Estee Lauder Companies Inc vs UiPath Inc — how do they compare? Estee Lauder Companies Inc trades at $94.6 (market cap $34.17B), while UiPath Inc trades at $13.34 (market cap $6.91B). The key difference: Estee Lauder Companies Inc is far larger — about 4.9× UiPath Inc's market cap, and Estee Lauder Companies Inc pays a 1.48% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Estee Lauder Companies Inc for 122 Days and UiPath Inc for 139 Days on average.
| EL | PATH | |
|---|---|---|
Market Cap | $34.17B | $6.91B |
Volume | 3,921,497 | 34,321,250 |
Sector | Consumer Staples | Technology |
52-Week High | $119.61 | $19.29 |
52-Week Low | $67.23 | $9.38 |
Typical Hold Time | 122 Days | 139 Days |
Enterprise Value | $39.92B | $5.70B |
Dividend Yield | 1.48% | — |
Signals from Pluang's Aura AI — not financial advice
Estée Lauder (EL) trades at $94.45, up 1.17% with a bullish technical signal from moving averages. The company shows mixed fundamentals with a high P/E ratio of 188.9 but strong gross margins of 75.5%. Recent earnings beats in Q4 2025 and Q1 2026 contrast with a net loss of $1.13B in 2025. Analyst consensus is positive with 47.8% buy ratings and a $103 price target. Recent developments include AI partnerships and leadership changes.
Outlook remains cautiously optimistic as the company navigates profitability challenges while investing in digital transformation. Key opportunities include margin recovery and AI-driven growth initiatives, balanced against competitive pressures and execution risks in the beauty sector. The stock offers potential upside to analyst targets if turnaround efforts succeed.
UiPath (PATH) trades at $13.07, down 0.23% on the day, amid a bearish technical signal and mixed earnings history. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while net income is expected to turn positive. Recent news highlights AI partnerships and product innovations, but the stock faces headwinds from cautious analyst sentiment and technical resistance.
The outlook for PATH is cautiously optimistic, with strong revenue growth and a path to profitability offering upside potential, but risks include execution challenges and competitive pressures. The consensus price target of $15.13 suggests moderate upside from current levels, though investor sentiment remains divided.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →